FundX Investment Group’s AbbVie ABBV Stock Holding History

FundX Investment Group’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-19,060	Closed	-$1.69M	–	33
2019 Q4	$1.69M	Buy	19,060 +60	+0.3%	+$4.98K	0.46%	28
2019 Q3	$1.44M	Hold	19,000	–	–	0.51%	21
2019 Q2	$1.38M	Hold	19,000	–	–	0.57%	21
2019 Q1	$1.53M	Hold	19,000	–	–	0.52%	24
2018 Q4	$1.75M	Hold	19,000	–	–	0.65%	23
2018 Q3	$1.8M	Hold	19,000	–	–	0.99%	12
2018 Q2	$1.76M	Sell	19,000 -131	-0.7%	-$12.8K	0.87%	13
2018 Q1	$1.81M	Buy	19,131 +131	+0.7%	+$14.4K	0.95%	9
2017 Q4	$1.84M	Hold	19,000	–	–	0.93%	12
2017 Q3	$1.69M	Hold	19,000	–	–	0.71%	12
2017 Q2	$1.38M	Hold	19,000	–	–	0.56%	17
2017 Q1	$1.24M	Hold	19,000	–	–	0.52%	26
2016 Q4	$1.19M	Hold	19,000	–	–	0.42%	25
2016 Q3	$1.2M	Buy	+19,000	New	+$1.23M	0.31%	29

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

FundX Investment Group's ABBV Position: Q1 2020 in Review

FundX Investment Group sold out of AbbVie (ABBV) in Q1 2020, closing a stake of 19,060 shares — an estimated $1.69M sold.

FundX Investment Group first reported a position in ABBV in Q3 2016 and held it in 14 quarters. The position peaked at $1.84M in Q4 2017. 2,225 funds tracked by Wall St. Rank hold ABBV as of Q1 2020.

FundX Investment Group reported no remaining AbbVie position as of Q1 2020 after selling out during the quarter.
FundX Investment Group sold 19,060 AbbVie shares in Q1 2020, an estimated $1.69M.
FundX Investment Group first reported a position in AbbVie in Q3 2016 and held it in 14 quarters.
FundX Investment Group's AbbVie position peaked at $1.84M in Q4 2017.
2,225 funds tracked by Wall St. Rank held AbbVie as of Q1 2020.

Based on FundX Investment Group's 13F filing for Q1 2020, filed 24 Apr 2020.